Scientists?: “Bee keepers almost never develop Multiple Sclerosis”

I’ve been writing and reporting about the latest news and information on Multiple Sclerosis and autoimmune diseases for a little over a year now, and at times I think I’ve covered everything. (I mean, how many times can the press report about the promise of oral MS therapy that still hasn’t hit the market!)

So I was a bit shocked, or should I say, “stung” by this small blurb from a newspaper in Oklahoma about the efficacy of bee sting venom in the treatment of multiple sclerosis.

Known as Apitherapy, the treatment of a number of illnesses with bee venom is neither novel nor new.  The early Egyptians used the venom, (or that is, by products) to cure arthritis, and ever since, Apitherapy has been credited for curing pain, skin conditions, burns, and much more.

How much more?

Well, according to this source, thousands of multiple-sclerosis patients in the United States are rumored to be using bee venom not in addition to their normal therapy but as an alternative to interferon and steroids.  While that number may be exaggerated, it is a fact that about 50 physicians nationwide use bee-venom therapy to relieve the symptoms of MS. That’s amazing considering much of this is unproven.

“Unproven you say?”

Well, not according to the Standing Commission on Apitherapy, which published a research paper (pdf file) written by two Russian medical scientists claiming an apparent,  undeniable truth.

“The best approval of the effectiveness of Apitherapy in the treatment of Multiple Sclerosis is a fact that cannot be contradicted,” said the researchers.  “Bee keepers almost never suffer multiple sclerosis.”

Now that’s science!

Cheers,

More in Today’s News:

• Multiple Sclerosis and Irrational Exuberance (sciencebasedmedicine.org)
• MS pill studies show better results, more risks (cbc.ca)
• Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS (Update1) (businessweek.com)
• FDA approves Ampyra (dalfampridine) for multiple sclerosis (MS) (medicineandtechnology.com)
• Italian group offers $4.5M to fund new MS research (ctv.ca)
• Two New Multiple Sclerosis Pills Show Promise in Late-Stage Studies (dailyfinance.com)
• Viatamin D deficiency in African Americans. (socialactions.net)
• What the New MS Drug Does (and What It Doesn’t Do) (blogs.wsj.com)
• Extavia (interferon beta-1b) approved for multiple sclerosis (medicineandtechnology.com)
• MS Patient Support Organizations (brassandivory.blogspot.com)

• Two New Multiple Sclerosis Pills Show Promise in Late-Stage Studies (dailyfinance.com)
• Viatamin D deficiency in African Americans. (socialactions.net)
• What the New MS Drug Does (and What It Doesn’t Do) (blogs.wsj.com)
• Extavia (interferon beta-1b) approved for multiple sclerosis (medicineandtechnology.com)
• MS Patient Support Organizations (brassandivory.blogspot.com)

Related posts:

1. Scientists Use Stem Cells to Reverse Symptoms of Multiple Sclerosis – Health…
2. 1st Ever Reversal of Multiple Sclerosis with Stem Cell Therapy
3. Fampridine said to improve mobility among Multiple Sclerosis patients
4. Ongoing Steroid Treatments Shown Effective Against Multiple Sclerosis
5. Neurologists will use oral Multiple Sclerosis drugs as first line treatment …